225 related articles for article (PubMed ID: 37532692)
21. Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma.
Sakai T; Aokage K; Neri S; Nakamura H; Nomura S; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Iyoda A; Tsuboi M; Ishii G
Lung Cancer; 2018 Dec; 126():64-71. PubMed ID: 30527194
[TBL] [Abstract][Full Text] [Related]
22. Detecting tumor-infiltrating Forkhead box P3-positive T cells in the prognosis of lung adenocarcinoma: Possible role of clustering tumor interleukin-12 subunit alpha and transforming growth factor beta 1 expression.
Matsuoka H; Matsubara H; Sugimura A; Uchida T; Kunimitsu T; Ichihara T; Oonuki Y; Miyauchi Y; Kondo T; Nakajima H
Adv Clin Exp Med; 2020 Jun; 29(6):715-725. PubMed ID: 32603557
[TBL] [Abstract][Full Text] [Related]
23. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
[TBL] [Abstract][Full Text] [Related]
24. [The Expression of RTN1 in Lung Adenocarcinoma and
Its Effect on Immune Microenvironment].
Zhu S; Zu L; Xu S
Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):385-395. PubMed ID: 35747917
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.
Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L
Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150
[TBL] [Abstract][Full Text] [Related]
26. ADAR1 is a prognostic biomarker and is correlated with immune infiltration in lung adenocarcinoma.
Yang W; Chen K; Yu Q; Liao R; He H; Peng Y; Yang Z; Zhang X
Cancer Med; 2023 Jul; 12(13):14820-14832. PubMed ID: 37162299
[TBL] [Abstract][Full Text] [Related]
27. Increased Tumor Intrinsic Growth Potential and Decreased Immune Function Orchestrate the Progression of Lung Adenocarcinoma.
Zhao Y; Shang J; Gao J; Han H; Gao Z; Yan Y; Zheng Q; Ye T; Fu F; Deng C; Ma Z; Zhang Y; Zheng D; Zheng S; Li Y; Cao Z; Shi L; Chen H
Front Immunol; 2022; 13():921761. PubMed ID: 35844495
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive analysis of microenvironment-related genes in lung adenocarcinoma.
Tao Y; Li Y; Liang B
Future Oncol; 2020 Aug; 16(24):1825-1837. PubMed ID: 32501723
[No Abstract] [Full Text] [Related]
29. Invasive FoxM1 phosphorylated by PLK1 induces the polarization of tumor-associated macrophages to promote immune escape and metastasis, amplified by IFITM1.
Xu R; Lee YJ; Kim CH; Min GH; Kim YB; Park JW; Kim DH; Kim JH; Yim H
J Exp Clin Cancer Res; 2023 Nov; 42(1):302. PubMed ID: 37968723
[TBL] [Abstract][Full Text] [Related]
30. Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma.
Hu Z; Jin X; Hong W; Sui Q; Zhao M; Huang Y; Li M; Wang Q; Zhan C; Chen Z
Cell Oncol (Dordr); 2023 Oct; 46(5):1351-1368. PubMed ID: 37079186
[TBL] [Abstract][Full Text] [Related]
31. [Comprehensive Analysis of the Relationship between m6A Methylation Patterns and Immune Microenvironment in Lung Adenocarcinoma].
Ke J; Cui J; Yang X; Du X; Ma B; Yu L
Zhongguo Fei Ai Za Zhi; 2022 May; 25(5):311-322. PubMed ID: 35599007
[TBL] [Abstract][Full Text] [Related]
32. Investigating the Clinico-Molecular and Immunological Evolution of Lung Adenocarcinoma Using Pseudotime Analysis.
Lee H; Choi H
Front Oncol; 2022; 12():828505. PubMed ID: 35311086
[TBL] [Abstract][Full Text] [Related]
33. Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment.
Akhave N; Zhang J; Bayley E; Frank M; Chiou SH; Behrens C; Chen R; Hu X; Parra ER; Lee WC; Swisher S; Solis L; Weissferdt A; Moran C; Kalhor N; Zhang J; Scheet P; Vaporciyan AA; Sepesi B; Gibbons DL; Heymach JV; Lee JJ; Wistuba II; Andrew Futreal P; Zhang J; Fujimoto J; Reuben A
Lung Cancer; 2022 Oct; 172():19-28. PubMed ID: 35973335
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis the prognostic and immune characteristics of mitochondrial transport-related gene SFXN1 in lung adenocarcinoma.
Liu W; Du Q; Mei T; Wang J; Huang D; Qin T
BMC Cancer; 2024 Jan; 24(1):94. PubMed ID: 38233752
[TBL] [Abstract][Full Text] [Related]
35. Lung adenocarcinoma patients with KEAP1 mutation harboring low immune cell infiltration and low activity of immune environment.
Cheng W; Xu B; Zhang H; Fang S
Thorac Cancer; 2021 Sep; 12(18):2458-2467. PubMed ID: 34328274
[TBL] [Abstract][Full Text] [Related]
36. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures.
Wu Q; Wang L; Wei H; Li B; Yang J; Wang Z; Xu J; Zhou YL; Zhang B
Int Immunopharmacol; 2020 Jun; 83():106477. PubMed ID: 32278127
[TBL] [Abstract][Full Text] [Related]
37. Comparative immunological landscape between pre- and early-stage LUAD manifested as ground-glass nodules revealed by scRNA and scTCR integrated analysis.
Wang Z; Yang L; Wang W; Zhou H; Chen J; Ma Z; Wang X; Zhang Q; Liu H; Zhou C; Guo Z; Zhang X
Cell Commun Signal; 2023 Nov; 21(1):325. PubMed ID: 37957625
[TBL] [Abstract][Full Text] [Related]
38. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
39. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma.
Li S; Li H; Cao Y; Geng H; Ren F; Li K; Dai C; Li N
Medicine (Baltimore); 2021 Aug; 100(32):e26474. PubMed ID: 34397869
[TBL] [Abstract][Full Text] [Related]
40. Targeting TAM-secreted S100A9 effectively enhances the tumor-suppressive effect of metformin in treating lung adenocarcinoma.
Sui Q; Hu Z; Liang J; Lu T; Bian Y; Jin X; Li M; Huang Y; Yang H; Wang Q; Lin Z; Chen Z; Zhan C
Cancer Lett; 2024 Jan; 581():216497. PubMed ID: 38008395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
